These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8998428)

  • 1. [Factors influencing the survival of children with Non-Hodgkin's disease].
    Kiselev AV
    Vestn Ross Akad Med Nauk; 1996; (10):26-8. PubMed ID: 8998428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors in non-Hodgkin's lymphomas].
    Mayáns J; Sanz G; Monzó E; Sancho-Tello R; Carrera MD; Figueres J; Sanz MA
    Rev Clin Esp; 1987 May; 180(8):420-5. PubMed ID: 3616025
    [No Abstract]   [Full Text] [Related]  

  • 3. [M-BACOD in advanced case of non-Hodgkin's lymphoma].
    Itami J; Ogata H; Shimizu K; Nemoto K; Yasuda S; Yoshida H; Mikata A; Arimizu N
    Gan No Rinsho; 1990 Mar; 36(4):499-504. PubMed ID: 1690824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of early stage primary tonsil non-Hodgkin's lymphoma].
    Gao YH; Li YX; Zhao LJ; Yuan ZY; Liu XF; Yu ZH
    Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):190-2. PubMed ID: 12864949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
    Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
    Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy for stage I aggressive non-Hodgkin's lymphoma.
    Kluin-Nelemans HC
    Croat Med J; 2002 Oct; 43(5):546-9. PubMed ID: 12402393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk-adjusted prognostic models for Hodgkin's disease (HD) and grade II non-Hodgkin's lymphoma (NHL II): validation on 6728 British National Lymphoma Investigation patients.
    Low SE; Horsman JM; Walters SJ; Hancock H; Smith P; Linch D; Hancock BW
    Br J Haematol; 2003 Jan; 120(2):277-80. PubMed ID: 12542487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
    Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C
    Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of recurrent high-grade non-Hodgkin's lymphoma].
    Schmitz N
    Internist (Berl); 1997 Feb; 38(2):143-9. PubMed ID: 9157059
    [No Abstract]   [Full Text] [Related]  

  • 11. Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma.
    Last KW; Cornelius V; Delves T; Sieniawska C; Fitzgibbon J; Norton A; Amess J; Wilson A; Rohatiner AZ; Lister TA
    J Clin Oncol; 2003 Jun; 21(12):2335-41. PubMed ID: 12805335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic strategies of mildly malignant non-Hodgkin's lymphoma].
    Wörmann B; Unterhalt M; Hiddemann W
    Internist (Berl); 1993 Feb; 34(2):132-8. PubMed ID: 8454426
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic strategies of highly malignant non-Hodgkin's lymphoma].
    Havemann K; Köppler H; Brittinger G; Steinke B
    Internist (Berl); 1993 Feb; 34(2):139-45. PubMed ID: 8454427
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
    Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin's lymphoma].
    Song LN; Cen XN; Ou JP; Liang ZY; Qiu ZX; Wang WS; Xu WL; Li Y; Wang MJ; Dong YJ; Yin Y; Sun YH; Liu W; Wang Q; Wang LH; Wang Y; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):387-91. PubMed ID: 23628038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of low-grade non-Hodgkin's lymphoma].
    Heinz R; Hopfinger-Limberger G
    Wien Klin Wochenschr; 1994; 106(10):321-6. PubMed ID: 8053200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary non-Hodgkin's lymphoma of bone in children.
    Glotzbecker MP; Kersun LS; Choi JK; Wills BP; Schaffer AA; Dormans JP
    J Bone Joint Surg Am; 2006 Mar; 88(3):583-94. PubMed ID: 16510826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in head and neck non-Hodgkin's lymphoma with special reference to serum lactic dehydrogenase and serum copper.
    Hisamitsu S; Shibuya H; Hoshina M; Horiuchi J
    Acta Oncol; 1990; 29(7):879-83. PubMed ID: 2261202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors of malignant lymphoma].
    Masaki N; Ikeda H; Matayoshi Y; Murayama S; Fujita M; Kozuka T
    Gan No Rinsho; 1989 Oct; 35(13):1591-5. PubMed ID: 2685396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy.
    Link MP; Donaldson SS; Berard CW; Shuster JJ; Murphy SB
    N Engl J Med; 1990 Apr; 322(17):1169-74. PubMed ID: 2183052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.